Medpace has Specialized Expertise to Accelerate Complex Respiratory Clinical Trials
According to the Global Burden of Disease Study 2023, chronic respiratory diseases accounted for 569.2 million cases and 4.2 million deaths worldwide. The post-COVID-19 burden of chronic respiratory disease remains significant, underscoring significant need for safe and effective therapies. Yet respiratory drug development remains challenging due to complex trial designs and longer durations.
As a full-service Clinical Research Organization (CRO), Medpace combines deep therapeutic expertise with operational excellence to streamline respiratory clinical development. Accelerate your path to approval with guidance from our integrated team of medical, operational, and regulatory experts. Our consistent track record in respiratory studies enables us to adapt to the unique requirements of each program, proactively manage complexity, and help you maximize your trial budget.
Making the Complex Seamless® in Global Respiratory Trials
Drive the successful execution of respiratory clinical trials with a partner that combines strong communication, early strategic planning, and extensive experience collaborating with global regulatory authorities. For over 30 years, Sponsors across emerging biotechnology and global pharmaceutical companies have trusted Medpace to lead their clinical development programs.
Gain a competitive advantage by leveraging Medpace’s global expertise and experience, with benefits that include:
Deep expertise in spirometry assessments, leveraging best practices for local reads and established relationships with respiratory service vendors to reduce variability, ensure high-quality data, and enable seamless endpoint collection
Comprehensive support via our dedicated global regulatory submissions and global regulatory affairs teams
ClinTrak®—Medpace’s proprietary clinical trial management system—provides integrated data and reporting across all aspects of a project and transforms complex data into interactive visualizations, enabling study teams to quickly spot trends, outliers, and actionable insights to enhance and streamline study management
Increased efficiency for addressing testing components through integrated services, including
“Navigating complex respiratory endpoints requires precision; our dedicated teams deliver data you can trust at every phase.”
Puneet Agarwal, MD
Medical Director, Respiratory, Medpace
Respiratory Clinical Trial Experts
In-house pulmonologists, clinical immunologists, and allergists add an additional layer of medical and scientific expertise and are embedded within the project team throughout the lifecycle of your trial. They provide leadership, consulting with Sponsors, along with training project teams and investigative sites to ensure our operational strategy is firmly aligned with your scientific and medical objectives. Additionally, our operational teams, including clinical trial managers and program coordinators, are therapeutically aligned to provide specialized training to sites and help mitigate challenges.
Alpha-1 Antitrypsin Deficiency (AATD) Consortium of Experts
The Medpace AATD Consortium brings together leading medical, operational, and regulatory experts from around the world who are dedicated to advancing AATD clinical development. The cross-functional team meets regularly to share lessons learned, apply best practices, and develop innovative solutions tailored to the unique challenges of AATD. With a shared commitment to accelerating progress, the consortium focuses on seamless execution of global AATD trials through collaboration and innovation.
Key focus areas include:
Analyzing the evolving competitive landscape to optimize country selection and enrollment
Developing and refining global patient recruitment strategies
Creating project management tools to accelerate startup and reduce operational hurdles
Sharing site-specific insights from KOLs to minimize duplication of efforts
Supporting ongoing education and training of new members
Strategic Approach to Recruitment & Retention
Medpace applies a multi-dimensional recruitment model to design and execute customized strategies for challenging patient populations. Our dedicated, in-house patient recruitment and retention team brings deep experience in recruiting respiratory patient populations, providing strategic guidance to accelerate patient enrollment. Through a patient-centric approach that minimizes burden while enhancing participant experience, we drive successful outcomes in study design, adherence, satisfaction, and data quality.
Strong, Long-Term Relationships
Our established relationships with global thought leaders, high-performing investigative sites, site networks, and patient advocacy organizations further strengthen recruitment and retention. This network helps facilitate strategic site selection, efficient start-up, targeted recruitment, and implementation of proven retention strategies—ensuring timely, high-quality enrollment that is key to the success of respiratory programs.
Hear Why Sites Partner with Medpace:
“Throughout the studies we collaborated on, Medpace provided consistent, results-driven support and clear alignment on objectives and endpoints in respiratory trials. Their timely support on patient-related questions and streamlined processes allowed us to exceed recruitment targets effortlessly. Their technical expertise, particularly in spirometry and ePROs, was a real asset to the study execution and the reliability of our study outcomes.”
Prof. Elena Bargagli, MD
Full Professor and Head of Respiratory Diseases Unit, Hospital University of Siena, Italy. Leading clinical and academic center specialized in complex, rare, and chronic pulmonary diseases and an active ERN-Lung member, WASOG recognized center of excellence.
